Evidence Files
Ashwagandha: 3,000 Years of Ayurvedic Use and the First Decent Clinical Trials Are Actually Promising
Ashwagandha has been used in Ayurvedic medicine for 3,000 years. For most of that time, "used for centuries" was the only available evidence. In the last decade, a modest but real body of randomised controlled trials has accumulated. The results are more honest than the marketing — and more positive than most trending supplements deserve.
Verdict
TREATMENT (partially confirmed)
We searched PubMed and Cochrane Library for ashwagandha evidence. Multiple RCTs exist, most using the standardised KSM-66 or Sensoril extracts. Evidence for stress and anxiety reduction is the most consistent finding. Evidence for testosterone, muscle mass, and cognitive enhancement is present but weaker and more mixed.
Why it went from Ayurveda to European pharmacy shelves
Ashwagandha (Withania somnifera) is an adaptogen — a class of herbs claimed to help the body resist physical and psychological stress. The active compounds are withanolides, which appear to modulate the HPA axis (the stress response system involving cortisol).
The European supplement market discovered ashwagandha around 2015-2018 as interest in adaptogens grew alongside broader wellness culture. Unlike many trend-driven supplements, ashwagandha had a pre-existing research infrastructure from Indian academic medicine — which meant clinical trials were already being conducted.
What makes ashwagandha unusual in the supplement space is that some of its claimed effects have been tested in genuine RCTs with placebo controls, and the results aren't entirely disappointing. This puts it in a different category from most herbs that ride wellness trends without any supporting data.
What the clinical trials actually show
- Stress and anxiety — the strongest evidence: multiple RCTs (60-90 day duration) show statistically significant reductions in perceived stress and cortisol levels; effect sizes are moderate but consistent
- Sleep quality — several RCTs show improvements in sleep onset and quality, likely mediated through cortisol reduction and direct GABAergic effects
- Testosterone and male fertility — some RCTs show modest increases in testosterone and sperm quality; effect sizes small, longer-term data limited
- Muscle strength and recovery — small RCTs in resistance-trained adults show modest benefits; industry-funded studies show larger effects than independent ones
- Cognitive function — limited trials, mostly small; some signal for reaction time and memory, not enough to draw firm conclusions
- Extract standardisation matters — KSM-66 and Sensoril are the most studied extracts; raw powder products may have different active compound profiles
What the supplement industry claims vs. what trials show
Common marketing claims
"Reduces stress, boosts testosterone, builds muscle, sharpens focus, improves sleep, fights fatigue, balances hormones." Often positioned as a complete wellness solution.
What the RCTs actually support
Stress reduction: reasonably supported. Sleep quality: some support. Testosterone: modest signal in men with low-normal levels. Muscle mass: small effect in exercising adults. Cognitive enhancement in healthy adults: insufficient evidence. The honest version is narrower — but it's real.
Our Conclusion
Ashwagandha is one of the more honest stories in the supplement world — it has genuine clinical trials, the primary indication (stress/anxiety reduction) shows consistent positive signals, and the effect sizes are modest rather than miraculous. It's not a cure for chronic stress, it won't replace sleep or exercise, and most of the more ambitious claims (testosterone, muscle, cognition) rest on weaker evidence. But for people looking for evidence-based options in the adaptogen space, ashwagandha has earned a cautious recommendation for stress management that most trending supplements haven't.
This article is for informational purposes only and does not constitute medical advice. Trick or Treatment analyses the presence of clinical studies in open scientific databases — PubMed and Cochrane Library. The absence of studies in these databases does not automatically mean a drug is ineffective, but it does mean its effectiveness has not been confirmed by evidence-based medicine standards. Any treatment decisions should be made together with your doctor.